Literature DB >> 27298415

Reply to R.L. Bowen et al, M. Froehner et al, J.L. Leow et al, and C. Brady et al.

Kevin T Nead1, Greg Gaskin2, Cariad Chester3, Samuel Swisher-McClure4, Joel T Dudley5, Nicholas J Leeper3, Nigam H Shah2.   

Abstract

Mesh：

Substances：

Year:  2016        PMID： 27298415      PMCID： PMC5019764          DOI： 10.1200/JCO.2016.67.9449

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  11 in total

1.  Radiotherapy and short-term androgen deprivation for localized prostate cancer.

Authors:  Christopher U Jones; Daniel Hunt; David G McGowan; Mahul B Amin; Michael P Chetner; Deborah W Bruner; Mark H Leibenhaut; Siraj M Husain; Marvin Rotman; Luis Souhami; Howard M Sandler; William U Shipley
Journal:  N Engl J Med       Date:  2011-07-14       Impact factor: 91.245

2.  A 'green button' for using aggregate patient data at the point of care.

Authors:  Christopher A Longhurst; Robert A Harrington; Nigam H Shah
Journal:  Health Aff (Millwood)       Date:  2014-07       Impact factor: 6.301

3.  Androgen Deprivation Therapy and Risk of Alzheimer's Disease: Importance of Holistic Geriatric Oncology Assessment.

Authors:  Claire Brady; Kieran O'Connor; Derek G Power
Journal:  J Clin Oncol       Date:  2016-06-13       Impact factor: 44.544

4.  Androgen Deprivation Therapy and Alzheimer's Disease.

Authors:  Michael Froehner; Manfred P Wirth
Journal:  J Clin Oncol       Date:  2016-06-13       Impact factor: 44.544

5.  Association of Androgen Deprivation Therapy With Alzheimer's Disease: Unmeasured Confounders.

Authors:  Jeffrey J Leow; Alexander P Cole; Maxine Sun; Quoc-Dien Trinh
Journal:  J Clin Oncol       Date:  2016-06-13       Impact factor: 44.544

6.  Not All Androgen Deprivation Therapies Are Created Equal: Leuprolide and the Decreased Risk of Developing Alzheimer's Disease.

Authors:  Richard L Bowen; Tracy Butler; Craig S Atwood
Journal:  J Clin Oncol       Date:  2016-06-13       Impact factor: 44.544

7.  Luteinizing-hormone releasing hormone therapy and the risk of death from Alzheimer disease.

Authors:  Anthony V D'Amico; Michelle H Braccioforte; Brian J Moran; Ming-Hui Chen
Journal:  Alzheimer Dis Assoc Disord       Date:  2010 Jan-Mar       Impact factor: 2.703

8.  Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial.

Authors:  Michel Bolla; Laurence Collette; Léo Blank; Padraig Warde; Jean Bernard Dubois; René-Olivier Mirimanoff; Guy Storme; Jacques Bernier; Abraham Kuten; Cora Sternberg; Johan Mattelaer; José Lopez Torecilla; J Rafael Pfeffer; Carmel Lino Cutajar; Alfredo Zurlo; Marianne Pierart
Journal:  Lancet       Date:  2002-07-13       Impact factor: 79.321

9.  Androgen Deprivation Therapy and Future Alzheimer's Disease Risk.

Authors:  Kevin T Nead; Greg Gaskin; Cariad Chester; Samuel Swisher-McClure; Joel T Dudley; Nicholas J Leeper; Nigam H Shah
Journal:  J Clin Oncol       Date:  2015-12-07       Impact factor: 44.544

Review 10.  Cancer survivorship issues: life after treatment and implications for an aging population.

Authors:  Julia H Rowland; Keith M Bellizzi
Journal:  J Clin Oncol       Date:  2014-07-28       Impact factor: 44.544
View more
  1 in total

1.  Type of Androgen Deprivation Therapy and Risk of Dementia Among Patients With Prostate Cancer in Taiwan.

Authors:  Wen-Kuan Huang; Chi-Hung Liu; See-Tong Pang; Jia-Rou Liu; John Wen-Cheng Chang; Chuang-Chi Liaw; Cheng-Lung Hsu; Yung-Chang Lin; Lai-Chu See
Journal:  JAMA Netw Open       Date:  2020-08-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.